Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort Study

BACKGROUND: Clinical efficacy of sacubitril/valsartan administered for the recommended indication of chronic heart failure (CHF) patients with New York Heart Association (NYHA) classes II-III appears to be higher than one would expect based on the drug-induced variations of the left ventricular ejec...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vecchis, Renato, Paccone, Andrea, Di Maio, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785293/
https://www.ncbi.nlm.nih.gov/pubmed/31636797
http://dx.doi.org/10.14740/cr910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785293/
https://www.ncbi.nlm.nih.gov/pubmed/31636797
http://dx.doi.org/10.14740/cr910

Ejemplares similares